Successful Phase 2 clinical trial for neflamapimod in mild-to-moderate Lewy body dementia

by University of North Carolina at Chapel Hill School of MedicineCredit: CC0 Public DomainEIP Pharma announced on October 6 that a phase 2 study in patients with mild-to-moderate Lewy body dement

Updated on: April 01,2024

Successful Phase 2 clinical trial for neflamapimod in mild-to-moderate Lewy body dementia

by University of North Carolina at Chapel Hill School of MedicineCredit: CC0 Public DomainEIP Pharma announced on October 6 that a phase 2 study in patients with mild-to-moderate Lewy body dement

Updated on:April 01,2024

Alzheimer's in one sibling raises risk of shortened lifespan in others

by Leigh Hopper,University of Southern CaliforniaCredit: CC0 Public DomainAn Alzheimer's diagnosis in a sibling raises the risk of a shortened lifespan in other family members—even those wit

Updated on: February 24,2024

Alzheimer's in one sibling raises risk of shortened lifespan in others

by Leigh Hopper,University of Southern CaliforniaCredit: CC0 Public DomainAn Alzheimer's diagnosis in a sibling raises the risk of a shortened lifespan in other family members—even those wit

Updated on:February 24,2024

Testing memory over four weeks could predict Alzheimer's disease risk

by University of BristolCredit: CC0 Public DomainNew research suggests testing people's memory over four weeks could identify who is at higher risk of developing Alzheimer's disease befor

Updated on: May 05,2024

Testing memory over four weeks could predict Alzheimer's disease risk

by University of BristolCredit: CC0 Public DomainNew research suggests testing people's memory over four weeks could identify who is at higher risk of developing Alzheimer's disease befor

Updated on:May 05,2024

Cognitive impairment afflicts majority of stroke patients

by Wenche Margrethe Kulmo,Norwegian University of Science and TechnologyCredit: Marcus Aurelius from PexelsParalysis and difficulty speaking are well-known problems following a stroke. Establish

Updated on: February 18,2024

Cognitive impairment afflicts majority of stroke patients

by Wenche Margrethe Kulmo,Norwegian University of Science and TechnologyCredit: Marcus Aurelius from PexelsParalysis and difficulty speaking are well-known problems following a stroke. Establish

Updated on:February 18,2024

Clinical trial results for lecanemab are a significant step for Alzheimer's, but not a historic breakthrough

by University of New South WalesAmyloid plaques and neurofibrillary tangles occur in the brains of patients with Alzheimer's disease. Credit: Ian JosonPartner companies Eisai and Biogen recen

Updated on: March 30,2024

Clinical trial results for lecanemab are a significant step for Alzheimer's, but not a historic breakthrough

by University of New South WalesAmyloid plaques and neurofibrillary tangles occur in the brains of patients with Alzheimer's disease. Credit: Ian JosonPartner companies Eisai and Biogen recen

Updated on:March 30,2024

Metabolism linked to brain health

by University of South AustraliaCredit: MART PRODUCTION from PexelsEvery three seconds, someone in the world is diagnosed with dementia. And while there is no known cure, changes in the brain can

Updated on: April 01,2024

Metabolism linked to brain health

by University of South AustraliaCredit: MART PRODUCTION from PexelsEvery three seconds, someone in the world is diagnosed with dementia. And while there is no known cure, changes in the brain can

Updated on:April 01,2024

Skin cells from frontotemporal dementia patients may reveal disease mechanisms and biomarkers for drug research

by University of Eastern FinlandFibroblasts of C9-HRE carriers show unaltered C9orf72 levels, express RNA foci, but do not display DPR proteins. a TaqMan assay from fibroblast RNA for C9orf72 all

Updated on: May 28,2024

Skin cells from frontotemporal dementia patients may reveal disease mechanisms and biomarkers for drug research

by University of Eastern FinlandFibroblasts of C9-HRE carriers show unaltered C9orf72 levels, express RNA foci, but do not display DPR proteins. a TaqMan assay from fibroblast RNA for C9orf72 all

Updated on:May 28,2024

Protein misfolding as a risk marker for Alzheimer's disease

by German Cancer Research CenterCredit: CC0 Public DomainIn symptom-free individuals, the detection of misfolded amyloid-β protein in the blood indicates a considerably higher risk of Alzheimer&#

Updated on: May 20,2024

Protein misfolding as a risk marker for Alzheimer's disease

by German Cancer Research CenterCredit: CC0 Public DomainIn symptom-free individuals, the detection of misfolded amyloid-β protein in the blood indicates a considerably higher risk of Alzheimer&#

Updated on:May 20,2024

Brain signals can predict how often a news article is shared online

by Hailey Reissman,University of PennsylvaniaCredit: Unsplash/CC0 Public DomainFor years, researchers at the Communication Neuroscience Lab at the Annenberg School for Communication and their pa

Updated on: January 12,2024

Brain signals can predict how often a news article is shared online

by Hailey Reissman,University of PennsylvaniaCredit: Unsplash/CC0 Public DomainFor years, researchers at the Communication Neuroscience Lab at the Annenberg School for Communication and their pa

Updated on:January 12,2024

Overlooked proteins may be key to better diagnosis of Alzheimer's

by University of California, San FranciscoCredit: Pixabay/CC0 Public DomainIn a new study of Alzheimer's disease, researchers at UC San Francisco have discovered that a relatively unstudied f

Updated on: April 29,2024

Overlooked proteins may be key to better diagnosis of Alzheimer's

by University of California, San FranciscoCredit: Pixabay/CC0 Public DomainIn a new study of Alzheimer's disease, researchers at UC San Francisco have discovered that a relatively unstudied f

Updated on:April 29,2024

Tiny blood vessels in the brain could be the key in treating vascular dementia

by University of SouthamptonTiny blood vessels in the brain could be the key in treating vascular dementia. Credit: University of SouthamptonResearchers from the University of Southampton are to

Updated on: May 18,2024

Tiny blood vessels in the brain could be the key in treating vascular dementia

by University of SouthamptonTiny blood vessels in the brain could be the key in treating vascular dementia. Credit: University of SouthamptonResearchers from the University of Southampton are to

Updated on:May 18,2024

It is not clear whether new Alzheimer's drugs will make a difference at a population level, say researchers

byUniversity of CambridgeCredit: CC0 Public DomainCambridge researchers have cast doubt on whether new amyloid immunotherapy drugs will have the desired effect of significantly reducing the impa

Updated on: August 08,2024

It is not clear whether new Alzheimer's drugs will make a difference at a population level, say researchers

byUniversity of CambridgeCredit: CC0 Public DomainCambridge researchers have cast doubt on whether new amyloid immunotherapy drugs will have the desired effect of significantly reducing the impa

Updated on:August 08,2024